Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cromolyn Sodium for COVID-19 Pneumonia
NCT05077917Phase 3Terminated
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Nov 2021
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium cromoglycate in COVID-19 pneumonia, sponsored by Texas Tech University Health Sciences Center. Started Nov 2021; status: terminated.
02
Drugs
sodium cromoglycate
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05077917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05077917.